2015

  1. Randomised clinical trial: vercirnon, an oral CCR9 antagonist,vs. placebo as induction therapy in active Crohn’s disease

  2. Efficacy of mesalazine or beclomethasone dipropionate enema or their combination in patients with distal active ulcerative colitis

  3. Early combo (antiTNF+antimetabolite) treatment vs conventional in CD

  4. Autologous Hematopoetic Stem Cell Transplantation for Refractory Crohn Disease

  5. Therapeutic Targets in IBD

  6. Budesonide foam for distal UC